🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David D. Stenehjem

University of Minnesota

ORCID: 0000-0002-1831-285X

Also affiliated with American Association of Colleges of Pharmacy, University of Utah, University of Minnesota, Duluth

MedicineEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).”.

A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.168
N/A
0DataRank · unranked
11 citations

David D. Stenehjem, Pamala A. Jacobson, Emil Lou, Andrew C. Nelson, Karen M. Kuntz +1 more

Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.24.993923
N/A
0DataRank · unranked
3 citations

Pierre Wallet, Lance Pflieger, David D. Stenehjem, Xuan Liu, Patrick A. Cosgrove +11 more

Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.723
N/A
0DataRank · unranked
0 citations

David D. Stenehjem, Neeraj Agarwal, Andrew W. Hahn, Deepika Sirohi, Prayushi Sharma +3 more

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-19-1580
N/A
0DataRank · unranked
2 citations

Brandon S. Walker, Trang H. Au, Zachary Rivers, Jennifer Ose, Christopher I. Li +4 more

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

Oncotarget(2022)10.18632/oncotarget.28178
N/A
0DataRank · unranked
7 citations

Hillevi Bauer, Trang H. Au, Jyothi U. Menon, Sudhir Unni, Dao Tran +15 more

Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data

The Pharmacogenomics Journal(2022)10.1038/s41397-022-00276-6
N/A
0DataRank · unranked
3 citations

Helen M. Parsons, Pamala A. Jacobson, Karen M. Kuntz, Joel F. Farley, David D. Stenehjem +1 more

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers

Advances in Hematology(2025)10.1155/ah/9924808
N/A
0DataRank · unranked
2 citations

Andre Hejazi, Vonetta L. Williams, Craig Comperatore, Srinivas K. Tantravahi, Najla Al Ali +14 more